These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 6786254)
21. The use of the three-phase bone scan in the early diagnosis of heterotopic ossification (HO) and in the evaluation of Didronel therapy. Freed JH; Hahn H; Menter R; Dillon T Paraplegia; 1982 Aug; 20(4):208-16. PubMed ID: 6215609 [TBL] [Abstract][Full Text] [Related]
22. The roles of serum alkaline and bone alkaline phosphatase levels in predicting heterotopic ossification following spinal cord injury. Citak M; Grasmücke D; Suero EM; Cruciger O; Meindl R; Schildhauer TA; Aach M Spinal Cord; 2016 May; 54(5):368-70. PubMed ID: 26643987 [TBL] [Abstract][Full Text] [Related]
23. Risk factors for heterotopic ossification in patients with spinal cord injury: a case-control study of 264 patients. Citak M; Suero EM; Backhaus M; Aach M; Godry H; Meindl R; Schildhauer TA Spine (Phila Pa 1976); 2012 Nov; 37(23):1953-7. PubMed ID: 22614800 [TBL] [Abstract][Full Text] [Related]
24. Muscle localization of heterotopic ossification following spinal cord injury. Ohlmeier M; Suero EM; Aach M; Meindl R; Schildhauer TA; Citak M Spine J; 2017 Oct; 17(10):1519-1522. PubMed ID: 28456672 [TBL] [Abstract][Full Text] [Related]
25. An unusual location for heterotopic ossification: lumbar anterior longitudinal ligament. Czyrny JJ; Glasauer FE J Spinal Cord Med; 1995 Jul; 18(3):194-9. PubMed ID: 7552424 [TBL] [Abstract][Full Text] [Related]
26. Long-term radial extracorporeal shock wave therapy for neurogenic heterotopic ossification after spinal cord injury: A case report. Li Y; Zhu Y; Xie Z; Jiang C; Li F J Spinal Cord Med; 2022 May; 45(3):476-480. PubMed ID: 32397914 [No Abstract] [Full Text] [Related]
27. Clinical observations on fractures and heterotopic ossification in the spinal cord and traumatic brain injured populations. Garland DE Clin Orthop Relat Res; 1988 Aug; (233):86-101. PubMed ID: 3135969 [TBL] [Abstract][Full Text] [Related]
28. Association between alendronate, serum alkaline phosphatase level, and heterotopic ossification in individuals with spinal cord injury. Ploumis A; Donovan JM; Olurinde MO; Clark DM; Wu JC; Sohn DJ; O'Connor KC J Spinal Cord Med; 2015 Mar; 38(2):193-8. PubMed ID: 24820653 [TBL] [Abstract][Full Text] [Related]
29. Incidence and risk factors in the appearance of heterotopic ossification in spinal cord injury. Bravo-Payno P; Esclarin A; Arzoz T; Arroyo O; Labarta C Paraplegia; 1992 Oct; 30(10):740-5. PubMed ID: 1448303 [TBL] [Abstract][Full Text] [Related]
30. Prevention and treatment of heterotopic ossification after spinal cord injury. Banovac K; Sherman AL; Estores IM; Banovac F J Spinal Cord Med; 2004; 27(4):376-82. PubMed ID: 15484668 [TBL] [Abstract][Full Text] [Related]
31. Evaluation and management of heterotopic ossification in patients with spinal cord injury. Banovac K; Gonzalez F Spinal Cord; 1997 Mar; 35(3):158-62. PubMed ID: 9076866 [TBL] [Abstract][Full Text] [Related]
32. Persistent hypercoagulation associated with heterotopic ossification in patients with spinal cord injury long after injury has occurred. Perkash A; Sullivan G; Toth L; Bradleigh LH; Linder SH; Perkash I Paraplegia; 1993 Oct; 31(10):653-9. PubMed ID: 8259328 [TBL] [Abstract][Full Text] [Related]